Maryland Attorney General Anthony G. Brown announced a $39.1 million multistate settlement with generic drug manufacturer Apotex over allegations of price-fixing and limiting competition, with affected consumers eligible for compensation. The settlement is part of ongoing antitrust litigation against multiple pharmaceutical companies accused of conspiring to inflate drug prices, with Maryland joining nearly all U.S. states and territories in the legal action.